📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of ß-catenin signaling. (2017)

First Author: Berwick DC

Attributed to: Regulation of Wnt and calcium signalling by the Parkinson's disease protein LRRK2 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13024-017-0153-4

PubMed Identifier: 28103901

Publication URI: http://europepmc.org/abstract/MED/28103901

Type: Journal Article/Review

Volume: 12

Parent Publication: Molecular neurodegeneration

Issue: 1

ISSN: 1750-1326